<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="41481">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02566369</url>
  </required_header>
  <id_info>
    <org_study_id>RD.06.SPR.18251</org_study_id>
    <nct_id>NCT02566369</nct_id>
  </id_info>
  <brief_title>Efficacy and Safety of CD5789 50μg/g Cream Versus Vehicle Cream in Acne Vulgaris</brief_title>
  <official_title>A Multi-Center, Randomized, Double-Blind, Parallel-Group Vehicle Controlled Study To Compare The Efficacy And Safety Of CD5789 50μg/g Cream Versus Vehicle Cream In Subjects With Acne Vulgaris</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Galderma R&amp;D</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Galderma R&amp;D</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Assessment of the efficacy and safety of CD5789 50μg/g cream applied once daily for 12 weeks
      in subjects with acne vulgaris.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Clinical Trial for each subject is approximately 14 weeks and are randomized to one of the
      two treatments for 12 weeks. Subjects must be 9 years of age and older with acne vulgaris.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">September 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2017</primary_completion_date>
  <phase>Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double Blind (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Success rate, defined as the percentage of subjects who achieve an Investigator Global Assessment (IGA) score of 1 (almost clear) or 0 (Clear) and at least a 2-grade improvement</measure>
    <time_frame>From Baseline to Week 12</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1200</enrollment>
  <condition>Acne Vulgaris</condition>
  <arm_group>
    <arm_group_label>CD5789 50μg/g Cream</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>CD5789 50μg/g Cream</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Placebo Cream</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo cream</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>CD5789 50μg/g cream</intervention_name>
    <description>CD5789 50µg/g cream applied once daily for 12 weeks.</description>
    <arm_group_label>CD5789 50μg/g Cream</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Placebo cream</intervention_name>
    <description>Placebo cream applied once daily for 12 weeks</description>
    <arm_group_label>Placebo Cream</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  The subject is a male or female, 9 years of age or older, at Screening visit.

          -  The Subject has moderate acne at Screening and Baseline.

          -  The subject is a female of non childbearing potential

          -  The subject is a female of childbearing potential with a negative pregnancy test and
             who is strictly abstinent or who agrees to use an effective and approved
             contraceptive method for the duration of the study and at least 1 month after the
             last study drug application.

        Exclusion Criteria:

          -  The subject has severe forms of acne (e.g., acne conglobate, acne fulminant) or
             secondary acne form (e.g.,chloracne, drug-induced acne, etc.).

          -  The subject has any uncontrolled or serious disease or any medical or surgical
             condition that may either interfere with the interpretation of the trial results
             and/or put the subject at significant risk (according to the Investigator's judgment)
             if the subject takes part to the trial.

          -  The subject has been exposed to excessive ultraviolet (UV) radiation within one month
             prior to the Baseline visit or the subject is planning intense UV exposure during the
             study (i.e., occupational exposure to the sun, sunbathing, tanning salon use,
             phototherapy, etc.)

          -  The subject is unwilling to refrain from use of prohibited medication during the
             clinical trial
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jerry Tan, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Windsor Clinical Research</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Galderma</last_name>
    <email>Perfect1@galderma.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8530)</name>
      <address>
        <city>Glendale</city>
        <state>Arizona</state>
        <zip>85308</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8511)</name>
      <address>
        <city>Phoenix</city>
        <state>Arizona</state>
        <zip>85018</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8509)</name>
      <address>
        <city>Hot Springs</city>
        <state>Arkansas</state>
        <zip>71913</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8355)</name>
      <address>
        <city>Rogers</city>
        <state>Arkansas</state>
        <zip>72758</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8456)</name>
      <address>
        <city>Beverly Hills</city>
        <state>California</state>
        <zip>90212</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8526)</name>
      <address>
        <city>Clovis</city>
        <state>California</state>
        <zip>93612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8224)</name>
      <address>
        <city>Fremont</city>
        <state>California</state>
        <zip>94538</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8509)</name>
      <address>
        <city>Fullerton</city>
        <state>California</state>
        <zip>92835</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8507)</name>
      <address>
        <city>Huntington Beach</city>
        <state>California</state>
        <zip>92647</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8425)</name>
      <address>
        <city>Newport Beach</city>
        <state>California</state>
        <zip>92663</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8052)</name>
      <address>
        <city>Oceanside</city>
        <state>California</state>
        <zip>92056</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8528)</name>
      <address>
        <city>Santa Ana</city>
        <state>California</state>
        <zip>92701</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8160)</name>
      <address>
        <city>Santa Monica</city>
        <state>California</state>
        <zip>91301</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8443)</name>
      <address>
        <city>Temecula</city>
        <state>California</state>
        <zip>92592</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8510)</name>
      <address>
        <city>Englewood</city>
        <state>Colorado</state>
        <zip>80113</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8370)</name>
      <address>
        <city>Boynton Beach</city>
        <state>Florida</state>
        <zip>33437</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8543)</name>
      <address>
        <city>Fort Lauderdale</city>
        <state>Florida</state>
        <zip>33316</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8522)</name>
      <address>
        <city>North Miami Beach</city>
        <state>Florida</state>
        <zip>33162</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8531)</name>
      <address>
        <city>Orange Park</city>
        <state>Florida</state>
        <zip>32073</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8213)</name>
      <address>
        <city>Ormond Beach</city>
        <state>Florida</state>
        <zip>32174</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8529)</name>
      <address>
        <city>Sanford</city>
        <state>Florida</state>
        <zip>32771</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8455)</name>
      <address>
        <city>St. Petersburg</city>
        <state>Florida</state>
        <zip>33708</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8523)</name>
      <address>
        <city>Tampa</city>
        <state>Florida</state>
        <zip>33609</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8126)</name>
      <address>
        <city>West Palm Beach</city>
        <state>Florida</state>
        <zip>33401</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8189)</name>
      <address>
        <city>Snellville</city>
        <state>Georgia</state>
        <zip>30078</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8367)</name>
      <address>
        <city>Arlington Heights</city>
        <state>Illinois</state>
        <zip>60005</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8366)</name>
      <address>
        <city>Plainfield</city>
        <state>Indiana</state>
        <zip>46168</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8532)</name>
      <address>
        <city>Overland Park</city>
        <state>Kansas</state>
        <zip>66215</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8069)</name>
      <address>
        <city>Louisville</city>
        <state>Kentucky</state>
        <zip>40202</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8012)</name>
      <address>
        <city>Glenn Dale</city>
        <state>Maryland</state>
        <zip>20769</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8525)</name>
      <address>
        <city>Rockville</city>
        <state>Maryland</state>
        <zip>20850</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8541)</name>
      <address>
        <city>Quincy</city>
        <state>Massachusetts</state>
        <zip>02169</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8512)</name>
      <address>
        <city>Bay City</city>
        <state>Michigan</state>
        <zip>48706</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8033)</name>
      <address>
        <city>Clinton Township</city>
        <state>Michigan</state>
        <zip>48038</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8226)</name>
      <address>
        <city>Warren</city>
        <state>Michigan</state>
        <zip>48088</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8521)</name>
      <address>
        <city>St. Joseph</city>
        <state>Missouri</state>
        <zip>64506</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8027)</name>
      <address>
        <city>St. Louis</city>
        <state>Missouri</state>
        <zip>63141</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8544)</name>
      <address>
        <city>Lincoln</city>
        <state>Nebraska</state>
        <zip>68502</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8108)</name>
      <address>
        <city>Las Vegas</city>
        <state>Nevada</state>
        <zip>89144</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8420)</name>
      <address>
        <city>Newington</city>
        <state>New Hampshire</state>
        <zip>03801</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8506)</name>
      <address>
        <city>Hackensack</city>
        <state>New Jersey</state>
        <zip>07601</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8500)</name>
      <address>
        <city>Brooklyn</city>
        <state>New York</state>
        <zip>11203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8514)</name>
      <address>
        <city>Hickory</city>
        <state>North Carolina</state>
        <zip>28602</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8195)</name>
      <address>
        <city>Beachwood</city>
        <state>Ohio</state>
        <zip>44122</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8016)</name>
      <address>
        <city>Cincinnati</city>
        <state>Ohio</state>
        <zip>45255</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (8188)</name>
      <address>
        <city>Hershey</city>
        <state>Pennsylvania</state>
        <zip>17033</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8369)</name>
      <address>
        <city>Charleston</city>
        <state>South Carolina</state>
        <zip>29414</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8117)</name>
      <address>
        <city>Knoxville</city>
        <state>Tennessee</state>
        <zip>37917</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8515)</name>
      <address>
        <city>Nashville</city>
        <state>Tennessee</state>
        <zip>37203</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8542)</name>
      <address>
        <city>Arlington</city>
        <state>Texas</state>
        <zip>76017</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (#8513)</name>
      <address>
        <city>Austin</city>
        <state>Texas</state>
        <zip>78705</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8245)</name>
      <address>
        <city>Dallas</city>
        <state>Texas</state>
        <zip>75231</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8214)</name>
      <address>
        <city>Salt Lake City</city>
        <state>Utah</state>
        <zip>84117</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8351)</name>
      <address>
        <city>Seattle</city>
        <state>Washington</state>
        <zip>98104</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8215)</name>
      <address>
        <city>Calgary</city>
        <state>Alberta</state>
        <zip>T3A 2N1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8154)</name>
      <address>
        <city>Winnipeg</city>
        <state>Manitoba</state>
        <zip>R3C 0N2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8038)</name>
      <address>
        <city>Hamilton</city>
        <state>Ontario</state>
        <zip>L8N 1V6</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8426)</name>
      <address>
        <city>London</city>
        <state>Ontario</state>
        <zip>N5X 2P1</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8026)</name>
      <address>
        <city>Markham</city>
        <state>Ontario</state>
        <zip>L3P 1X2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8135)</name>
      <address>
        <city>North Bay</city>
        <state>Ontario</state>
        <zip>P1B 3Z7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8168)</name>
      <address>
        <city>Oakville</city>
        <state>Ontario</state>
        <zip>L6J 7W5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8340)</name>
      <address>
        <city>Peterborough</city>
        <state>Ontario</state>
        <zip>K9J 5K2</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8338)</name>
      <address>
        <city>Richmond Hill</city>
        <state>Ontario</state>
        <zip>L4B 1A5</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>Galderma Investigational Site (# 8060)</name>
      <address>
        <city>Windsor</city>
        <state>Ontario</state>
        <zip>N8W 5L7</zip>
        <country>Canada</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Galderma Investigational Site</last_name>
    </contact>
  </location>
  <location_countries>
    <country>Canada</country>
    <country>United States</country>
  </location_countries>
  <link>
    <url>http://www.acne.com/</url>
  </link>
  <verification_date>October 2016</verification_date>
  <lastchanged_date>October 4, 2016</lastchanged_date>
  <firstreceived_date>October 1, 2015</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Efficacy</keyword>
  <keyword>Safety</keyword>
  <keyword>Acne vulgaris</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Acne Vulgaris</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
